Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2017, ended Jan 31, 2017 | $202B |
| FY2018, ended Jan 31, 2018 | $315B |
| FY2019, ended Jan 31, 2019 | $275B |
| FY2020, ended Jan 31, 2020 | $324B |
| FY2021, ended Jan 31, 2021 | $396B |
| FY2022, ended Jan 31, 2022 | $385B |
| FY2023, ended Jan 31, 2023 | $388B |
| FY2024, ended Jan 31, 2024 | $444B |
| FY2025, ended Jan 31, 2025 | $787B |
| FY2026, ended Jan 31, 2026 | $950B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $882B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2017, ended Jan 31, 2017 | $486B |
| FY2018, ended Jan 31, 2018 | $500B |
| FY2019, ended Jan 31, 2019 | $514B |
| FY2020, ended Jan 31, 2020 | $524B |
| FY2021, ended Jan 31, 2021 | $559B |
| FY2022, ended Jan 31, 2022 | $573B |
| FY2023, ended Jan 31, 2023 | $611B |
| FY2024, ended Jan 31, 2024 | $648B |
| FY2025, ended Jan 31, 2025 | $681B |
| FY2026, ended Jan 31, 2026 | $713B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $736B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2017, ended Jan 31, 2017 | $13.6B | $21.1B |
| FY2018, ended Jan 31, 2018 | $9.86B | $18.3B |
| FY2019, ended Jan 31, 2019 | $6.67B | $17.4B |
| FY2020, ended Jan 31, 2020 | $14.9B | $14.6B |
| FY2021, ended Jan 31, 2021 | $13.5B | $25.8B |
| FY2022, ended Jan 31, 2022 | $13.7B | $11.1B |
| FY2023, ended Jan 31, 2023 | $11.7B | $12.0B |
| FY2024, ended Jan 31, 2024 | $15.5B | $15.1B |
| FY2025, ended Jan 31, 2025 | $19.4B | $12.7B |
| FY2026, ended Jan 31, 2026 | $21.9B | $14.9B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $22.1B | $13.5B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2017, ended Jan 31, 2017 | $6.87B |
| FY2018, ended Jan 31, 2018 | $6.76B |
| FY2019, ended Jan 31, 2019 | $7.72B |
| FY2020, ended Jan 31, 2020 | $9.46B |
| FY2021, ended Jan 31, 2021 | $17.7B |
| FY2022, ended Jan 31, 2022 | $14.8B |
| FY2023, ended Jan 31, 2023 | $8.63B |
| FY2024, ended Jan 31, 2024 | $9.87B |
| FY2025, ended Jan 31, 2025 | $9.04B |
| FY2026, ended Jan 31, 2026 | $10.7B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $11.5B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2017, ended Jan 31, 2017 | $39.4B |
| FY2018, ended Jan 31, 2018 | $39.0B |
| FY2019, ended Jan 31, 2019 | $50.6B |
| FY2020, ended Jan 31, 2020 | $49.7B |
| FY2021, ended Jan 31, 2021 | $44.5B |
| FY2022, ended Jan 31, 2022 | $38.1B |
| FY2023, ended Jan 31, 2023 | $39.2B |
| FY2024, ended Jan 31, 2024 | $40.5B |
| FY2025, ended Jan 31, 2025 | $39.1B |
| FY2026, ended Jan 31, 2026 | $44.8B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $50.4B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 12.8% since FY17.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2017, ended Jan 31, 2017 | 9.10B |
| FY2018, ended Jan 31, 2018 | 8.85B |
| FY2019, ended Jan 31, 2019 | 8.61B |
| FY2020, ended Jan 31, 2020 | 8.50B |
| FY2021, ended Jan 31, 2021 | 8.45B |
| FY2022, ended Jan 31, 2022 | 8.26B |
| FY2023, ended Jan 31, 2023 | 8.09B |
| FY2024, ended Jan 31, 2024 | 8.06B |
| FY2025, ended Jan 31, 2025 | 8.02B |
| FY2026, ended Jan 31, 2026 | 7.97B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | 7.93B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2017, ended Jan 31, 2017 | $8.30B | $596M |
| FY2018, ended Jan 31, 2018 | $8.30B | $626M |
| FY2019, ended Jan 31, 2019 | $7.41B | $773M |
| FY2020, ended Jan 31, 2020 | $5.72B | $854M |
| FY2021, ended Jan 31, 2021 | $2.63B | $1.17B |
| FY2022, ended Jan 31, 2022 | $9.79B | $1.16B |
| FY2023, ended Jan 31, 2023 | $9.92B | $1.58B |
| FY2024, ended Jan 31, 2024 | $2.78B | $2.09B |
| FY2025, ended Jan 31, 2025 | $4.49B | $2.77B |
| FY2026, ended Jan 31, 2026 | $8.09B | $3.60B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $6.99B | — |
Valuation
At current price- Market Cap
- $947B
- P/E
- 42.9×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 1.3×
- Price / Book
- 9.6×
- EV / EBITDA
- 20.8×
Growth
Trailing 12 months- Revenue (TTM)
- $736B
- Revenue Growth YoY
- 6.2%
- Revenue CAGR 3Y
- 5.3%
- Revenue CAGR 5Y
- 5.0%
- EPS Growth YoY
- 4.2%
- Net Income Growth YoY
- 3.4%
Profitability
Trailing 12 months- Gross Margin
- 25.2%
- Operating Margin
- 4.4%
- Net Margin
- 3.0%
- FCF Margin
- 1.8%
- Return on Equity
- 23.4%
Earnings
Trailing 12 months- Net Income
- $22.1B
- EPS (diluted)
- $2.76
- EBITDA
- $47.4B
- Operating Income
- $32.3B
Balance Sheet
As of Jul 31, 2026- Cash and cash equivalents
- $11.5B
- Total Debt
- $50.4B
- Net Debt
- $38.9B
- Total Assets
- $294B
- Total Liabilities
- $189B
- Shareholders' Equity
- $98.2B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $42.9B
- Capital Expenditure
- $29.4B
- Free Cash Flow
- $13.5B
Dividends and risk
Last 12 months- Dividend Yield
- 0.8%
- Dividend / Share
- $0.98
- Beta (5Y)
- 0.57
Every ratio is calculated from the company’s reported figures.